Mode
Text Size
Log in / Sign up

Deep Heat Plus Drug Boosts Lung Cancer Response Rates

Share
Deep Heat Plus Drug Boosts Lung Cancer Response Rates
Photo by Navy Medicine / Unsplash

Deep Heat Plus Drug Boosts Lung Cancer Response Rates

Imagine a patient facing a tough battle with advanced lung cancer. The standard path involves powerful drugs that fight the disease from the inside. But sometimes the cancer is stubborn and does not respond well to these medicines alone. Doctors are always looking for ways to make these treatments work better without adding extra pain or risk.

New research offers a fresh idea to help these patients. The study looked at a specific type of lung cancer called squamous non-small cell lung cancer. This form of the disease is often harder to treat than others. It affects many people and can be very difficult to manage once it spreads.

But here is the twist. The doctors added a physical therapy called deep hyperthermia to the drug regimen. This technique uses heat to warm the tumor area deeply inside the body. The goal was to make the cancer cells more sensitive to the drugs. Think of it like turning up the heat in a room to make a fire burn faster.

The Heat Makes Drugs Work Better

The body works like a complex factory where cells do specific jobs. Cancer cells hijack this system and grow out of control. Heat therapy acts like a switch that changes how these cells behave. When the tumor gets warm, the cancer cells become more vulnerable to attack.

This is similar to how a lock and key work. The drugs are the key that tries to open the lock on the cancer cell. Sometimes the lock is too strong for the key. Heat weakens the lock so the key can fit in easily. This allows the immune system and chemotherapy to destroy the cancer more effectively.

Researchers looked at 100 patients who started treatment between January 2021 and early January 2023. Half of the patients received the standard drugs of tislelizumab and chemotherapy. The other half got the same drugs plus the deep heat treatment. The main goal was to see how many tumors shrank or disappeared.

The results showed a clear difference between the two groups. The group with heat therapy saw a response rate of 66.0 percent. This means two out of three patients saw their tumors shrink or vanish. The standard group had a response rate of 46.0 percent. That is a big jump in success for the patients getting the added heat.

The safety profile stayed the same for both groups. Patients did not face more side effects with the heat added. This is a huge win because it means doctors can use this method without worrying about new risks. The patients tolerated the treatment well.

This doesn't mean this treatment is available yet.

The study also looked at how long patients lived and how long the disease stayed under control. These numbers did not show a big difference between the groups yet. The heat group did not live significantly longer in this small study. But the higher response rate is still very important. It means the disease stays in check longer for more people.

This finding gives doctors a new tool to fight advanced lung cancer. It offers hope for patients whose tumors are not responding to drugs alone. The treatment is safe and easy to add to existing plans. Patients might ask their doctors if this option is right for them.

It is important to talk with a doctor about all treatment choices. Every patient is different and needs a plan that fits their specific situation. This new method could become a standard part of care in the future. It shows that combining different types of therapy can lead to better outcomes.

This study was done at one hospital with 100 patients. That is a good start but more data is needed. Larger studies will help confirm these results across different hospitals. Researchers will likely test this on more types of lung cancer too.

Approval for this method will take time and more testing. It is a careful process to ensure safety for everyone. The next step is to see if other cancer centers can use this technique. If the results hold up, more patients could benefit from this powerful combination.

Share
More on advanced squamous non-small cell lung cancer